CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Activist investor Glenview Capital Management has reduced its ownership stake in CVS Health (NYSE:CVS) after the pharmacy ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares after the ...

Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health following the insurer's "healthy ...

Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. and pledged to keep the rest, ...

Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...

We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 ...

Transitions of care—moving patients from one care site to another—continues to be a challenge in healthcare. | Startup Kouper ...

Pharmaceutical company Novo Nordisk (NVO) came out swinging Wednesday morning as the stock initially jumped on its first quarter earnings beat ($0.99 per share vs. estimates of $0.94). Revenue figures ...